"10.1371_journal.pctr.0010018","plos clinical trials","2006-07-28T00:00:00Z","Gillian Hales; Chris Birch; Suzanne Crowe; Cassy Workman; Jennifer F Hoy; Matthew G Law; Anthony D Kelleher; Douglas Lincoln; Sean Emery","National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia; Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia; Burnet Centre, Melbourne, Australia; AIDS Research Initiative, Sydney, Australia; Department of Medicine Alfred Hospital, Monash University, Melbourne, Australia","GH and SE designed the study. CW, MGL, DL, and SE analyzed the data. SC, CW, and JFH enrolled patients. SC, JFH, and ADK collected data or did experiments for the study. GH wrote the first draft of the paper. SC, CW, JFH, MGL, ADK, and SE contributed to the writing of the paper. GH wrote the protocol and coordinated the study. SC assisted in study design and presentation of results. ADK supervised the conduct of the resistance assays for one of the major sites that contributed data to this collaborative project and ensured the internal quality control for these data.","Competing Interests. SE received travel support from BMS, Chiron, GlaxoSmithKline, and Merck Sharpe and Dohme; received research funding from Abbott, Australia Technology, Bristol Myers Squibb, Boehringer-Ingleheim, Chiron, GlaxoSmithKline, Gilead, Merck Sharpe and Dohme, and Virax Immunotherapeutics; and received honoraria from Bristol Myers Squibb, Chiron, and Roche. GH has been employed by Roche Products this year, but was not their employee during the conduct of this study. CW receives research funds from Tibotec, Johnson and Johnson, Roche, Merck Sharpe and Dohme, Abbott, GlaxoSmithKline, Boehringer-Ingleheim, Pfizer, and Novartis. CW is on the advisory board of Merck Sharpe and Dohme, Tibotec, Roche, and Abbott, and received travel grants from Roche and Abbott. CW has no stocks in any pharmaceutical companies that she is aware of, but does have an investment account with a management fund and does not know what companies they invest in. MGL has received travel grants from GlaxoSmithKline and consultancy from Johnson and Johnson Research. SC, JFH, ADK, and DL declare that they have no competing interests.","2006","07","Gillian Hales","GH",9,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
